Proactive Investors - Run By Investors For Investors

Craneware's top line growth on track

Craneware's top line growth on track


Craneware (LON:CRW), the software solutions provider focused on the US healthcare market, saw first half revenue grow in line with expectations.

Revenue of US$20.1mln in the first half of the current financial year was up from US$18.8mln in the first half of last year.

Underlying earnings (EBITDA) grew by around 15% in comparison to last year’s interim EBITDA of US$4.65mln.

Keith Neilson, chief executive of Craneware, commented: "The increased levels of sales activity discussed at the time of our final results in September 2012 have begun to contribute to revenue growth. Fiscal and regulatory pressures on US hospitals, including the recently announced expansion of the Medicare Recovery Audit Contractor Programme, continues to drive interest in our suite of software solutions and we are confident in the ongoing strength of our position within this growing area of the US healthcare market."

Shares in Craneware were unchanged in early trading.


Register here to be notified of future CRW Company articles


March 11 2014
November 08 2012
February 28 2012

Related Articles

June 09
Rightster investors have endured a torrid time of late. Here, with the help of the new CEO, we consider why it may have turned a corner.
March 09

The first two months of the year have seen an upturn in the stock market fortunes of Instem (LON:INS), which supplies IT applications to companies working on the early phases of developing drugs and chemicals.

December 17 2014

Back office workforce optimisation software pioneer eg solutions is to raise £3.2mln to invest in a push for faster growth.

© Proactive Investors 2015